Governor Cuomo Announces 12 Community-Based Pop-Up Vaccination Sites Coming Online This Week to Vaccinate More Than 3,700 New Yorkers

 

Sites Will Vaccinate More Than 3,700 People This Week and Bolster State's Commitment to Ensuring Fairness and Equity in Vaccine Distribution Process

Community-Based 'Pop Up' Vaccination Sites Have Enabled Over 46,000 New Yorkers to Receive First Dosage of Vaccine 

Host Sites and Partner Providers Conduct Outreach Within Their Communities and Work with Community Leaders and Organizations to Identify Eligible New Yorkers and Schedule Vaccination Appointments

 Governor Andrew M. Cuomo today announced 12 community-based pop-up vaccination sites coming online this week at community centers, public housing complexes and cultural centers. These sites are expected to vaccinate more than 3,700 people throughout the week, with more sites coming online every week. Since January 15, more than 100 community-based pop-up sites administered over 46,000 first doses of the COVID-19 vaccine dose. As has been the case with previous pop-up sites, these sites will be re-established in three weeks to administer second doses.

Moving forward as the federal vaccine supply increases, New York will continue to establish these sites at all 33 NYCHA Senior Housing Developments, which house more than 7,600 seniors. Pop-up locations will also continue to be established at other public housing complexes statewide, as well as at more than 300 churches and cultural centers which have volunteered to house these sites through Governor Cuomo's Vaccine Equity Task Force.

"Community-based vaccination sites are a key component of New York's effort to ensure all eligible New Yorkers have a chance to get the vaccine quickly and fairly, right in their community," Governor Cuomo said. "Social equity and fairness has been at the center of our response, but this isn't purely an access issue. We need New Yorkers to trust the vaccine and actually take it. We're tackling skepticism and distrust head-on through our local partnerships and pop-up sites and bringing the vaccine directly in the communities that have been hit hardest by this pandemic."

The establishment of many of these vaccination sites was made possible by the deployment of these vaccination kits and through partnerships with multiple public and private health care providers. Host sites and partner providers conduct outreach within their communities and work with community leaders and organizations to identify eligible New Yorkers and schedule vaccination appointments. The 12 sites being established this week are located at the addresses below:

NEW YORK CITY
Middletown Plaza NYCHA
3033 Middletown Road
Bronx, NY 10461
Open: February 25, 2021; 9:00 AM-5:00 PM 

Wayside Baptist Church
1746 Broadway
Brooklyn, NY 11207
Open: February 25, 2021-February 26, 2021; 9:00 AM-6:00 PM 

Convent Avenue Baptist Church
420 W 145th St
New York, NY 10031
Open: February 26, 2021; 9:00 AM-5:00 PM 

LONG ISLAND
Freeport Recreation Center
130 East Merrick Road
Freeport, NY11520
Open: February 25, 2021; 8:00 AM-12:00 PM 

La Espiguita Soccer
1795 Brentwood Road
Brentwood, NY 11717
Open: February 26, 2021; 8:00 AM-12:00 PM 

CENTRAL NEW YORK
Boys & Girls Club - East
2100 E Fayette Street
Syracuse, NY 13224
Open: February 26, 2021; 9:00 AM-5:00 PM 

HUDSON VALLEY
Mulberry House Senior Center
62-70 West Main Street
Middletown, NY 10940
Open: February 27, 2021; 9:00 AM-4:00 PM
**all appointments already filled**

Newburgh Armory Unity Center
321 S William Street
Newburgh, NY 12550
Open: February 26, 2021; 9:00 AM-3:00 PM
**all appointments already filled** 

Mt. Kisco Senior Center
198 Carpenter Avenue
Mt. Kisco, NY 10549
Open: February 27, 2021; 9:00 AM-5:00 PM
**all appointments already filled** 

SOUTHERN TIER
American Civic Association
131 Front St
Binghamton, NY 13905
Open: February 26, 2021; 9:00 AM-4:30 PM 

FINGER LAKES
Livingston County Department of Social Services
1 Murray Hill Campus
Mt. Morris, NY 14510
Open: February 27, 2021; 9:00 AM-12:00 PM
**all appointments already filled** 

MOHAWK VALLEY
Riverfront Center
1290 Riverfront Center
Amsterdam, NY 12010
Open: February 27, 2021;10:00 AM-2:00 PM 

This continued development of community-based 'pop up' vaccination sites furthers Governor Cuomo's mandate of ensuring the fair and equitable distribution of the COVID-19 vaccine. In late 2020, the Governor announced the launch of New York's Vaccine Equity Task Force chaired by Secretary of State Rossana Rosado, Attorney General Letitia James, National Urban League President & CEO Marc Morial, and Healthfirst President & CEO Pat Wang. Since its establishment, the Task Force has continued work to ensure vulnerable and underserved communities are not left behind by breaking down the barriers to vaccination and ensuring there is equitable distribution of the vaccine across the state.

New York City to Install Rooftop Solar Arrays on 47 Public Schools, Wards Island Wastewater Resource Recovery Facility, and Mid-Hudson Locations

 

Two Developers Selected; Design Underway 

 

Installations to Generate 22 Megawatts of Solar Power and Energy Storage, Projects Help Accelerate City and State Clean Energy Goals

 The NYC Department of Citywide Administrative Services (DCAS) and the New York Power Authority (NYPA) today announced the selection of two firms to install rooftop solar arrays on nearly 50 public schools across the five boroughs, the Wards Island Wastewater Resource Recovery Facility in Manhattan, and three other water treatment facilities in Westchester, Delaware, and Ulster counties. The solar arrays will generate as much as 22 megawatts of solar power, enough to power 5,600 NYC residences, and reduce nearly 7,000 metric tons of CO₂ equivalent each year, which equates to removing more than 1,500 cars from city streets. Several of these facilities are expected to include energy storage systems that will store energy for use during periods of peak electricity demand. During peak demand, prices increase and dirtier energy sources are activated to meet the additional demand. Ameresco, a Framingham, Mass. headquartered clean technology integrator, and ENGIE North America with national headquarters in Houston, have been selected as the project developers.

 

“Our schools are not only tackling climate change in the classroom, but also on the rooftop,” said Lisette Camilo, Commissioner of the NYC Department of Citywide Administrative Services. “New solar installations on schools and other public facilities will generate green energy that will help achieve Mayor de Blasio’s goal of reducing citywide emissions 80% by 2050.” 

 

“Solar plus storage projects, especially on such a scale as these projects, will help both New York State and New York City work in lockstep to boost the availability of renewable power and achieve our mutual green energy goals,” said NYPA President and CEO Gil C. Quiniones. “Bringing solar energy to New York City facilities in diverse neighborhoods will help supply affordable, clean and reliable electricity throughout the five boroughs and support the state mandate for a 100 percent carbon-free electricity sector by 2040.”

 

The solar installations are currently planned for 47 NYC Department of Education (DOE) buildings spanning all five boroughs. Carbon emissions from public schools account for nearly one-third of emissions from the City’s building portfolio. Adding solar to schools provides carbon emissions reduction potential as well as opportunities for students to learn about the importance of sustainability and climate action. This project will incorporate a new clean power source into the school district’s infrastructure and allow the City to purchase power generated on-site as opposed to purchasing power from a utility company that may not use a renewable source. 

 

At the Department of Environmental Protection’s (DEP) Wards Island facility, a combination of ground-mounted, carport, rooftop and elevated canopy solar PV systems will be installed throughout the eight-facility complex, totaling over seven megawatts of solar PV capacity. Solar power generated will serve the loads of the plant, and a battery energy storage system will reduce peak energy demand. An additional 1.5 megawatts of capacity is expected to be installed at three City-owned facilities in the watershed, including the Catskill-Delaware Ultraviolet Light Disinfection Facility in Valhalla.

 

ENGIE will design, construct, own and operate the solar PV systems at the DOE sites while Ameresco will perform the same tasks at Wards Island and the other DEP sites. NYPA, acting as the clean energy advisor, will manage the projects to ensure they progress on budget and on time. The developers were selected through a competitive bidding process announced last June.

 

The City and NYPA conducted site assessments to identify the most feasible and appropriate locations to install solar PV systems to help the City achieve its renewable energy goals. Selected locations, amounting to nearly 70% of the total capacity, also support the State and City’s efforts to advance environmental justice as many of the sites are in areas with poorer air quality and lower median incomes. The project sites are anticipated to be interconnected behind the meter to buildings’ electrical systems. 

 

This initiative will help achieve Mayor Bill de Blasio’s goal of installing 100 MW of solar power on public buildings by 2025 and reducing citywide emissions 80 percent by 2050. The initiative will also help achieve Governor Andrew M. Cuomo’s statewide goal of having 70 percent of New York’s electricity come from renewable sources by 2030 and an 85 percent reduction in greenhouse gas emissions by 2050. NYPA will administer 20-year power purchase agreements for the City to buy the electricity output from each of the projects being managed by Ameresco and ENGIE.  

 

Kevin Moran, Chief School Operations Officer for the NYC Department of Education, said, “Student activism, lessons in our classrooms, and now solar panels on roofs are all evidence of our commitment to combating the effects of global warming. The young people of today are the inheritors of our planet and it is our obligation to do everything in our power to leave them with a livable, vibrant world and we are proud to join with our partner agencies to take this step in building on our commitment.”

Assemblyman Ron Kim - More on Cuomo's Corporate Legal Immunity

 

Why did Governor Cuomo give nursing homes immunity from Covid deaths?

Ron Kim

Was the corporate immunity linked to $1.5m in political contributions from lobbyists? Only a full investigation can help us find out

‘There is more than a good chance that he continued to listen to lobbyists after the budget – and the immunity clause – passed.’ Photograph: Johannes Eisele/AFP/Getty Images

Tue 23 Feb 2021 06.20 EST

342

Imagine fielding hundreds of calls from worried constituents at the peak of the first Covid-19 wave, trying to help scared families protect loved ones in nursing homes.

Imagine being stonewalled by those nursing homes and the department of health as you sought answers to life-and-death questions, knowing that Governor Andrew Cuomo’s directive forced these unprepared facilities to take in thousands of Covid-positive patients.

This was what I was going through as a New York state assemblyman when I received a call from a New York Times reporter about a corporate legal immunity provision that gave for-profit nursing homes and hospitals get-out-of-jail-free cards.

‘Meet the governor we’ve known all along’: how Cuomo fell from grace

Read more

My heart sank as I read it. I did not need a PhD or law degree to understand the repercussions of handing out legal immunity to for-profit nursing homes, which now had legal and criminal shields to disincentivize them from saving lives.

310 Days and Counting

 

No one has questioned me about nursing homes. It was that dictator up in Albany who is at fault.  

I still have 310 days to go, will he?

Assembly Member Nathalia Fernandez - Black HERstory Month Event, February 26th

 

Hello:

We would like to invite you all to join our “Black HERstory Month” virtual event with Assemblywoman Nathalia Fernandez.

The event will be held on Friday, February 26^th, at 7:00pm VIA Zoom. - Meeting ID: 886 9378 4432

Join us for a conversation about Black and Brown Girl Magic with Talitha Cumi and Alternatives of Not On My Watch

The conversation will include guest speaker:

• Pamela Damon, Youth Director

 

Best Regards,

New York State Assemblywoman Nathalia Fernandez

Former COO Of Publicly Traded Biopharmaceutical Company Sentenced For Accounting Fraud

 Audrey Strauss, the United States Attorney for the Southern District of New York, announced that WILLIAM TAYLOR, the former chief operating officer of MiMedx Group, Inc. (“MiMedx”), a publicly traded biopharmaceutical company, was sentenced today in Manhattan federal court to one year in prison for orchestrating a multimillion-dollar scheme to fraudulently inflate MiMedx’s revenue.  TAYLOR and co-defendant Parker H. Petit were found guilty on November 19, 2020, following a four-week jury trial before U.S. District Court Judge Jed S. Rakoff, who imposed today’s sentence.  Judge Rakoff sentenced Petit to one year in prison in a separate proceeding yesterday.

Manhattan U.S. Attorney Strauss said:  “William Taylor and his co-defendant used secret agreements and corrupt financial inducements to materially misstate quarterly and annual sales revenue of MiMedx.  They deceived the SEC, auditors, and the investing public.  Now Taylor, like Parker Petit yesterday, has been sentenced to prison for his crimes.”

According to the allegations contained in the Indictment and the evidence presented at trial:

MiMedx was headquartered in Marietta, Georgia, and its securities traded under the symbol “MDXG” on the NASDAQ.  MiMedx sold regenerative biologic products, such as skin grafts and amniotic fluid, both directly to end users, such as public and private hospitals, and to various stocking distributors, which, in turn, resold the product to end users. 

One of the most critical financial metrics disclosed in MiMedx’s public filings with the Securities and Exchange Commission (“SEC”), and touted in MiMedx’s accompanying press releases, was MiMedx’s quarterly and annual sales revenue.  Under Generally Accepted Accounting Principles (GAAP) and SEC guidance, a company like MiMedx that engages in the sale of products through a distributor may recognize revenue upon transfer of the product to a distributor if certain requirements are satisfied, including that delivery has occurred or services have been rendered, the seller’s price to the buyer is fixed or determinable, and collectability of payment is reasonably assured.  TAYLOR and Petit, MiMedx’s former chief executive officer, repeatedly demonstrated and touted their understanding of these rules governing revenue recognition.  They also publicly identified revenue as the principal metric reflecting MiMedx’s growth, and touted MiMedx’s consistent record of quarter-over-quarter revenue growth and meeting or exceeding revenue guidance in 17 consecutive quarters, from 2011 through year-end 2015.  By 2015, however, it became increasingly difficult for MiMedx to reach its revenue guidance due to decreased demand from certain distributors and the increasingly aggressive revenue targets that MiMedx had publicly announced. 

Confronted with the difficulties faced by MiMedx in meeting its quarterly and annual revenue guidance by legitimate means, TAYLOR and Petit orchestrated a fraudulent scheme to falsely recognize revenue upon the shipment of MiMedx product to four stocking distributors, CPM, SLR, Stability Biologics (“Stability”), and First Medical, in the second through fourth quarters of 2015.  TAYLOR and Petit caused MiMedx to report fraudulently inflated revenue figures to the investing public in order to ensure that the reported figures fell within MiMedx’s publicly announced revenue guidance, and to fraudulently convey to the investing public that MiMedx was accomplishing consistent growth quarter after quarter, as TAYLOR and Petit had falsely touted to the investing public.  The fraudulent scheme involved the following central features:

• As to CPM, in the second quarter of 2015, TAYLOR and Petit caused MiMedx fraudulently to recognize $1.4 million in revenue by (1) making a $200,000 sham “consulting” payment to CPM’s owner to bribe CPM to buy MiMedx product and (2) secretly agreeing to send CPM approximately $1.1 million of product it did not want and did not intend to sell, while promising that CPM could return the product to MiMedx and swap it for different product in a subsequent quarter.  TAYLOR and Petit entered into the sham “consulting” agreement to conceal that the payment was a bribe to purchase product, and CPM’s owner performed no consulting work for the payment.  Neither TAYLOR nor Petit disclosed to MiMedx’s outside auditors the “consulting” payment or product swap. 

• As to SLR, in the third quarter of 2015, TAYLOR and Petit caused MiMedx fraudulently to recognize $4.6 million in revenue by booking the revenue despite understanding that SLR would not make a timely payment for the product, and certainly would not do so within contractual terms.  To hide from MiMedx’s auditors that the collectability of payment from SLR was questionable, during the fourth quarter 2015, Petit arranged for his adult children to use a shell company to loan money to SLR (money that came from a trust fund established by Petit for their benefit), with the understanding that the loan proceeds would be used in substantial part to pay down SLR’s debt to MiMedx.

• As to Stability, in the third and fourth quarters of 2015, TAYLOR and Petit caused MiMedx improperly to recognize $2.6 million of revenue, where they (1) failed to agree with Stability on the essential terms of the deal, including when payment was due; (2) reached a secret understanding that Stability could swap or return unwanted product in subsequent quarters; and (3) understood that Stability could not pay for the product in a timely fashion.  In fact, TAYLOR later signed a sham distribution agreement to hide the fact that the original sale had been made without agreement on the essential terms.     

• As to First Medical, in the fourth quarter of 2015, TAYLOR caused MiMedx improperly to recognize $2.2 million in revenue by making an undisclosed promise to First Medical that it could return any product that it could not sell and that MiMedx would not leave First Medical with any losses.  To carry out the scheme, TAYLOR sent two emails four seconds apart to First Medical.  The first was a “cover story” that purported to require payment within a fixed period, as required by MiMedx’s accountants.  TAYLOR forwarded the first email to MiMedx’s accounting department.  The second email, sent only four seconds after the first, memorialized the true terms of the deal, which involved an agreement to defer payment and take back product if it could not be sold.  TAYLOR hid the second email from MiMedx’s internal accountants and outside auditors.  TAYLOR also arranged for a false audit “confirmation,” which falsely represented that First Medical was required to pay within a fixed period and omitted the true terms of the deal, to be provided to MiMedx’s outside auditors.

TAYLOR and Petit’s fraudulent manipulation of MiMedx’s revenue caused MiMedx to report materially inflated revenue in the second, third, and fourth quarters of 2015, and for the full year 2015.  In its 2015 10-K, MiMedx reported annual revenue that was fraudulently inflated by approximately $8.2 million.  Absent this fraudulent inflation of revenue, MiMedx would have missed both (1) its quarterly revenue guidance in the third and fourth quarters of 2015 and annual revenue guidance for 2015 and (2) analyst revenue consensus for the second through fourth quarters of 2015 and the full year 2015.  As a result of the fraud, shareholders sustained losses of approximately $35 million.

In addition to his prison term, TAYLOR, 52, of Marietta, Georgia, was ordered to pay a fine of $250,000. 

Ms. Strauss praised the investigative work of the United States Postal Inspection Service and thanked the SEC, which brought a separate civil action. 

This case is being handled by the Office’s Securities and Commodities Fraud Task Force. Assistant U.S. Attorneys Edward A. Imperatore, Scott A. Hartman, and Daniel M. Tracer are in charge of the prosecution.

Former CEO Of Publicly Traded Biopharmaceutical Company Sentenced For Accounting Fraud

 

 Audrey Strauss, the United States Attorney for the Southern District of New York, announced that PARKER H. PETIT, the former chief executive officer of MiMedx Group, Inc. (“MiMedx”), a publicly traded biopharmaceutical company, was sentenced today in Manhattan federal court to one year in prison for orchestrating a multimillion-dollar scheme to fraudulently inflate MiMedx’s revenue.  PETIT and co-defendant William Taylor were found guilty on November 19, 2020, following a four-week jury trial before U.S. District Court Judge Jed S. Rakoff, who imposed today’s sentence. 

Manhattan U.S. Attorney Strauss said:  “Parker Petit used secret agreements and corrupt financial inducements with four distributors to materially misstate the quarterly and annual sales revenue of MiMedx.  He deceived the SEC, auditors, and the investing public.  Now he has been sentenced to prison for his crimes.”

According to the allegations contained in the Indictment and the evidence presented at trial:

MiMedx was headquartered in Marietta, Georgia, and its securities traded under the symbol “MDXG” on the NASDAQ.  MiMedx sold regenerative biologic products, such as skin grafts and amniotic fluid, both directly to end users, such as public and private hospitals, and to various stocking distributors, which, in turn, resold the product to end users. 

One of the most critical financial metrics disclosed in MiMedx’s public filings with the Securities and Exchange Commission (“SEC”), and touted in MiMedx’s accompanying press releases, was MiMedx’s quarterly and annual sales revenue.  Under Generally Accepted Accounting Principles (GAAP) and SEC guidance, a company like MiMedx that engages in the sale of products through a distributor may recognize revenue upon transfer of the product to a distributor if certain requirements are satisfied, including that delivery has occurred or services have been rendered, the seller’s price to the buyer is fixed or determinable, and collectability of payment is reasonably assured.  PETIT and Taylor, MiMedx’s former chief operating officer, repeatedly demonstrated and touted their understanding of these rules governing revenue recognition.  They also publicly identified revenue as the principal metric reflecting MiMedx’s growth, and touted MiMedx’s consistent record of quarter-over-quarter revenue growth and meeting or exceeding revenue guidance in 17 consecutive quarters, from 2011 through year-end 2015.  By 2015, however, it became increasingly difficult for MiMedx to reach its revenue guidance due to decreased demand from certain distributors and the increasingly aggressive revenue targets that MiMedx had publicly announced. 

Confronted with the difficulties faced by MiMedx in meeting its quarterly and annual revenue guidance by legitimate means, PETIT and Taylor orchestrated a fraudulent scheme to falsely recognize revenue upon the shipment of MiMedx product to four stocking distributors, CPM, SLR, Stability Biologics (“Stability”), and First Medical, in the second through fourth quarters of 2015.  PETIT and Taylor caused MiMedx to report fraudulently inflated revenue figures to the investing public in order to ensure that the reported figures fell within MiMedx’s publicly announced revenue guidance, and to fraudulently convey to the investing public that MiMedx was accomplishing consistent growth quarter after quarter, as PETIT and Taylor had falsely touted to the investing public.  The fraudulent scheme involved the following central features:

• As to CPM, in the second quarter of 2015, PETIT and Taylor caused MiMedx fraudulently to recognize $1.4 million in revenue by (1) making a $200,000 sham “consulting” payment to CPM’s owner to bribe CPM to buy MiMedx product and (2) secretly agreeing to send CPM approximately $1.1 million of product it did not want and did not intend to sell, while promising that CPM could return the product to MiMedx and swap it for different product in a subsequent quarter.  PETIT and Taylor entered into the sham “consulting” agreement to conceal that the payment was a bribe to purchase product, and CPM’s owner performed no consulting work for the payment.  Neither PETIT nor Taylor disclosed to MiMedx’s outside auditors the “consulting” payment or product swap. 

• As to SLR, in the third quarter of 2015, PETIT and Taylor caused MiMedx fraudulently to recognize $4.6 million in revenue by booking the revenue despite understanding that SLR would not make a timely payment for the product, and certainly would not do so within contractual terms.  To hide from MiMedx’s auditors that the collectability of payment from SLR was questionable, during the fourth quarter 2015, PETIT arranged for his adult children to use a shell company to loan money to SLR (money that came from a trust fund established by PETIT for their benefit), with the understanding that the loan proceeds would be used in substantial part to pay down SLR’s debt to MiMedx.  PETIT did not disclose the loan to MiMedx’s outside auditors and made false and misleading statements to the auditors about SLR’s ability to pay MiMedx.

• As to Stability, in the third and fourth quarters of 2015, PETIT and Taylor caused MiMedx improperly to recognize $2.6 million of revenue, where they (1) failed to agree with Stability on the essential terms of the deal, including when payment was due; (2) reached a secret understanding that Stability could swap or return unwanted product in subsequent quarters; and (3) understood that Stability could not pay for the product in a timely fashion.  In fact, PETIT granted the right of return to Stability in a back-dated letter he hid from MiMedx’s internal accountants and outside auditors.     

• As to First Medical, in the fourth quarter of 2015, Taylor caused MiMedx improperly to recognize $2.2 million in revenue by making an undisclosed promise to First Medical that it could return any product that it could not sell and that MiMedx would not leave First Medical with any losses.  To carry out the scheme, Taylor sent two emails four seconds apart to First Medical.  The first was a “cover story” that purported to require payment within a fixed period, as required by MiMedx’s accountants.  Taylor forwarded the first email to MiMedx’s accounting department.  The second email, sent only four seconds after the first, memorialized the true terms of the deal, which involved an agreement to defer payment and take back product if it could not be sold.  Taylor hid the second email from MiMedx’s internal accountants and outside auditors.  Taylor also arranged for a false audit “confirmation,” which falsely represented that First Medical was required to pay within a fixed period and omitted the true terms of the deal, to be provided to MiMedx’s outside auditors.

PETIT’s and Taylor’s fraudulent manipulation of MiMedx’s revenue caused MiMedx to report materially inflated revenue in the second, third, and fourth quarters of 2015, and for the full year 2015.  In its 2015 10-K, MiMedx reported annual revenue that was fraudulently inflated by approximately $8.2 million.  Absent this fraudulent inflation of revenue, MiMedx would have missed both (1) its quarterly revenue guidance in the third and fourth quarters of 2015 and annual revenue guidance for 2015 and (2) analyst revenue consensus for the second through fourth quarters of 2015 and the full year 2015.  PETIT’s offense caused approximately $35 million in losses to MiMedx shareholders.

In addition to his prison term, PETIT, 81, of Marietta, Georgia, was ordered to pay a fine of $1 million. 

Taylor was found guilty of conspiracy to commit securities fraud, to make false statements in filings with the SEC, and to mislead auditors.  Taylor will be sentenced tomorrow at 4:00 p.m. before Judge Rakoff. 

Ms. Strauss praised the investigative work of the United States Postal Inspection Service and thanked the SEC, which brought a separate civil action. 

This case is being handled by the Office’s Securities and Commodities Fraud Task Force. Assistant U.S. Attorneys Edward A. Imperatore, Scott A. Hartman, and Daniel M. Tracer are in charge of the prosecution.

Assembly Member Nathalia Fernandez - Food Giveaway, February 25th

 

Hello:

On Thursday, February 25th our office will be holding a  Food Giveaway in partnership with New York Common Pantry, Lexa Bar and garden, and Senator Jamaal T. Bailey

The giveaway will be held at Lexa Bar and Garden, 357 East 204th Street - between 3:30pm - 5:00pm

*While Supplies Last*

We encourage all to attend and to let your families, neighbors, and friends know as well. 

Best Regards,

New York State Assemblywoman Nathalia Fernandez